Published in

Taylor and Francis Group, Expert Opinion on Investigational Drugs, 9(30), p. 923-930, 2021

DOI: 10.1080/13543784.2021.1972970

Links

Tools

Export citation

Search in Google Scholar

Sprifermin: a recombinant human fibroblast growth factor 18 for the treatment of knee osteoarthritis

Journal article published in 2021 by Jia Li ORCID, Xiaoshuai Wang ORCID, Guangfeng Ruan, Zhaohua Zhu ORCID, Changhai Ding ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO